Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience.


BACKGROUND Despite improvements in locoregional treatment of stages III/IV squamous cell carcinoma of the head and neck (HNSCC), local and distant failure rates remain high. An effective adjuvant therapy is required for these patients. Among novel approaches is radioimmunotherapy, in which monoclonal antibodies (MAbs) are used for selective delivery of… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.